| Cost of medication |
| “Some patients can’t really afford [NOACs], I think they’re something like 90 bucks a month or something. So I wouldn’t switch anyone over basically because of the cost difference.” |
| >Insurance coverage |
| “A lot depends on the demographics of your practice and the insurance issues within your patient population.” |
| “I deal with mostly an insured population. You know, so it’s less of an issue for me” |
| “Except that patients on Medicare who are these patients, ah, you know, might have to pay more out of pocket if they don’t have a secondary insurance.” |
| Cost influencing adherence |
| “If they can’t afford it they’re not gonna take it. They’re not gonna take it properly or they’re gonna take it every other day or cut a pill when they shouldn’t.” |
| “Because if they’re not going to afford it, a lot of times those patients aren’t gonna go to their doctor and be like, I can’t afford this, can I try something else. There’s the concern that they’re just gonna be like, I not gonna take this.” |
| Cost-effectiveness |
| “My gut sense is it’s (NOACs) cleaner and from a system standpoint it probably is more cost effective or efficient.” |
| “My colleagues are saying, and I agree, that, you know, we should, we should probably be prescribing them more because no one’s looking at really this, this monitoring cost, which is significant. Time and money, you know.” |
| “The individual still matters more to me than the public health” |
| “There’s a lot of things that we do in medicine that would be cost effective from a more like national or global standpoint. But when it comes time to patient care, patients don’t care about that.” |
